Humana Shares Rise Following Reports of Improved 2027 Medicare Star Ratings

Key Facts

1Humana shares rose following an Evercore report indicating improved Medicare Advantage Star ratings for 2027.

Humana HUM shares rose following an Evercore report indicating improved Medicare Advantage Star ratings for the 2027 plan year. Investing.com reported that the positive assessment is a significant driver for the stock, as these ratings are critical for determining bonus payments and the company's ability to attract beneficiaries.

HUM closed at $387.12 on October 8, 2026, with the session seeing a trading range between a low of $375.86 and a high of $399.19. The anticipated improvement in ratings helps offset previous regulatory concerns, supporting expectations for better future margins and sustained market share in the healthcare sector.